Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Journal of Clinical Immunology|May 1, 1989
The potential usefulness of interleukin-2 activated bone marrow cells as an active therapeutic tool against cytomegalovirus infection in a bone marrow transplantation settingR Agah, A MazumderCancer Immunology, Immunotherapy : CII|January 1, 1987
Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populationsR Agah, H Shau, A MazumderJournal of Biological Response Modifiers|February 1, 1990
Heterogeneity of cell surface structures involved in cytotoxicity mediated by lymphokine activated killer cellsP Bean, R Agah, A MazumderClinical Neurology and Neurosurgery|May 1, 1996
Fatal cerebral venous thrombosis as the initial manifestation of the antiphospholipid syndromeR Agah, L Rice, J WinikatesInternational Journal of Cell Cloning|May 1, 1992
Differential lysis of tumor target cells displayed by lymphokine activated killer (LAK) cell clonesP Bean, R Agah, A MazumderBlood|July 1, 1992
Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantationB S Charak, R Agah, A MazumderBlood|June 15, 1993
Granulocyte-macrophage colony-stimulating factor-induced antibody-dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantationB S Charak, R Agah, A MazumderIntensive Care Medicine|July 1, 1997
Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcomeR Agah, V Bandi, K K GuntupalliCancer Research|October 1, 1989
Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivoI Gill, R Agah, E Hu, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1989
Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantationR Agah, B Malloy, M Kerner, et al.Pageof 3